The Cartiva Implant Recall Explained – What Stryker Didn’t Tell You Until It Was Too Late

The Cartiva Implant Recall and What It Means for Patients

The Cartiva Synthetic Cartilage Implant was sold as a modern fix for big toe arthritis. Patients were told they could keep joint motion, avoid fusion, and get back to walking without pain. For many, the opposite happened. The device failed, pain returned, and revision surgery became the only option. In October 2024, Stryker announced a nationwide recall. By then, the damage was done for thousands of people.

This article explains the recall in plain English, what went wrong with the device, what Stryker knew, and what you can do if you were harmed. You can also visit our comprehensive Cartiva implant lawsuit overview to see how this recall connects to the growing wave of lawsuits and settlements. Our goal is to be clear, direct, and supportive so you can make informed decisions about your health and legal rights.

What Cartiva Was Supposed To Do

Cartiva is a small cylinder made of polyvinyl alcohol hydrogel. Surgeons place it into the first metatarsophalangeal joint to cushion bone on bone friction caused by hallux rigidus. The promise was simple: reduce pain and keep motion.

On paper, the idea sounded great. In real life, many patients saw pain, swelling, stiffness, and instability return quickly after surgery. Others felt clicking or grinding with each step. When surgeons checked imaging, they often saw that the implant had moved, sunk, or broken down inside the bone. These are some of the early warning signs discussed in our guide on how to tell if your Cartiva implant is failing.

Early Warning Signs Many Patients Never Heard About

Within a few years of launch, surgeons reported a wave of repeat surgeries. Some stopped using the device entirely. Patients posted online about constant pain and failed outcomes. While early marketing suggested a 13 percent failure rate, later reports from clinics and published studies described much higher real world failure and reoperation rates.

What does that mean for a patient? It means the device that was supposed to spare you from fusion often sent you back to the operating room for removal and fusion anyway. It also means more medical bills, more time off your feet, and more stress than you ever expected-issues we cover in The Hidden Costs of a Failed Cartiva Implant.

Why The Cartiva Implant Fails

Most failures trace to the material and design:

• Shrinkage and dehydration: The hydrogel can lose water and volume once implanted. As it shrinks, the fit loosens.
• Migration and subsidence: A loose implant can shift or sink into bone, causing pain and instability.
• Material fatigue: Daily loading from walking can lead to micro cracks or fragmentation of the implant.
• Inflammation and bone loss: The body may react to a failing implant with inflammation and osteolysis, making revision harder.
• Press fit limitations: With no permanent fixation, even small movements can start a failure cycle.

In simple terms, Cartiva often did not behave like durable cartilage inside a load bearing joint. The longer it was in place, the more likely it was to loosen, move, or break down. Our comparison of Cartiva vs. Toe Fusion explains why many surgeons have gone back to recommending fusion as a more stable and predictable option.

The October 2024 Recall in Plain English

On October 31, 2024, Stryker issued a recall for all sizes of the Cartiva implant distributed since 2016. Surgeons were told to stop using it and return any stock. Patients were told to contact their doctors if they had pain, swelling, or loss of motion.

For many, the recall notice confirmed what they already knew from lived experience: the implant was failing too often. A recall matters in two ways. First, it signals safety concerns that should have been addressed earlier. Second, it supports legal claims that the device was defective and that warnings were not adequate. We break this down in Inside the Cartiva Lawsuits, which explores what attorneys have uncovered about Stryker’s internal data and early warnings.

What Stryker Knew And When

Adverse event reports tied to Cartiva began building years before the recall. Surgeons reported loosening, subsidence, fracture, and painful returns to the operating room. Clinics published case series and studies showing high revision rates compared to fusion. By 2022, the pattern was hard to ignore.

Despite that, Cartiva was still marketed as a motion saving solution. Brochures and training focused on short term outcomes while downplaying long term performance issues. That gap between marketing and reality sits at the center of many lawsuits. It raises the same questions addressed in From Innovation to Injury – The Rise and Fall of the Cartiva Toe Implant: Why were patients not warned sooner, and how did such a promising idea go so wrong?

How The Recall Strengthens Lawsuits

In product liability cases, a recall does not automatically prove fault. But it is powerful evidence that a product posed safety risks. Plaintiffs now argue that Stryker and related entities:

• Sold a device with design and durability defects
• Failed to warn surgeons and patients as evidence mounted
• Misrepresented performance and durability in marketing
• Delayed corrective action while patients were harmed

If proven, these claims support compensation for medical costs, lost income, pain and suffering, and in some states punitive damages. Punitive damages are designed to punish reckless conduct and deter future misconduct. As the litigation expands, many legal observers believe it could grow into one of the largest medical device cases in years-an issue we explore further in Why the Cartiva Recall Could Be Bigger Than Anyone Expected.

Do You Qualify For A Cartiva Lawsuit

You may qualify if you received a Cartiva implant between 2016 and 2024 and later experienced one or more of the following:

• Revision surgery to remove the implant
• Conversion to fusion due to implant failure
• Persistent pain, swelling, stiffness, or loss of motion
• Imaging that shows loosening, migration, subsidence, fragmentation, or bone loss
• Medical expenses, missed work, or lasting limitations tied to the implant

Even if your implant has not been removed, ongoing symptoms can support a claim. Deadlines apply, and they vary by state, so it is wise to speak with an attorney as soon as possible. For a step-by-step overview of what evidence strengthens a claim, see our guide on building a strong Cartiva case.

Cartiva vs Fusion: What Patients Are Hearing Now

Many surgeons who once offered Cartiva now recommend fusion for severe arthritis. Fusion removes motion in the joint, but it is stable and predictable. Patients trade flexibility for pain relief and function. If you already have fusion after a failed Cartiva implant, you are not alone. That path is common and is a key factor in many claims. Learn more in Cartiva vs Toe Fusion.

We Are Here To Help

If your Cartiva implant failed, you deserve answers and a plan. Our team reviews medical records, works with experts, and fights to recover full and fair compensation. We handle the legal work so you can focus on your health. For a complete understanding of your legal rights and the latest updates, visit our main Cartiva Lawsuit page today.

Injured by a Failed Cartiva Implant? Call Alonso Krangle, LLP Today

If your Cartiva Synthetic Cartilage Implant failed or you’re experiencing pain, swelling, or stiffness after surgery, Alonso Krangle, LLP can help. Our attorneys represent patients nationwide in claims against Stryker and Cartiva, holding them accountable for defective medical devices that cause lasting harm.

Call [PHONE] or contact Alonso Krangle, LLP online for a free, no-obligation consultation. There are no upfront fees, and you pay nothing unless we win your case.